Novo Nordisk A/S (NVO) has a market capitalization of $174.74B and trades at $39.32. The 52-week range is 35.12-81.44.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of 1.7, Earnings Per Share (EPS) of $23.06, annual revenue of $297.2B.
The stock has a beta of 0.27, a last dividend of $1.3274, operates in the Healthcare sector.
